AAAAAA

   
Results: 1-25 | 26-50 | 51-66
Results: 1-25/66

Authors: Devereux, HL Burke, A Lee, CA Johnson, MA
Citation: Hl. Devereux et al., In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution, J MED VIROL, 66(1), 2002, pp. 8-12

Authors: Miners, AH Sabin, CA Tolley, KH Parnaby, A Lee, CA
Citation: Ah. Miners et al., Assessing the relationship between productivity levels and severity of haemophilia, HAEMOPHILIA, 7(5), 2001, pp. 459-463

Authors: Makris, M Baglin, T Dusheiko, G Giangrande, PLF Lee, CA Ludlam, CA Preston, FE Watson, HG Wilde, JT Winter, M
Citation: M. Makris et al., Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia, HAEMOPHILIA, 7(4), 2001, pp. 339-345

Authors: Webber, SE Marakovits, JT Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Lee, CA Srinivasan, B Moran, T Ford, CE Brothers, MA Harr, JEV Meador, JW Ferre, RA Worland, ST
Citation: Se. Webber et al., Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 11(20), 2001, pp. 2683-2686

Authors: Schechter, LM Lee, CA
Citation: Lm. Schechter et Ca. Lee, AraC/XylS family members, HilC and HilD, directly bind and derepress the Salmonella typhimurium hilA promoter, MOL MICROB, 40(6), 2001, pp. 1289-1299

Authors: Nitu-Whalley, IC Griffioen, A Harrington, C Lee, CA
Citation: Ic. Nitu-whalley et al., Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease, AM J HEMAT, 66(4), 2001, pp. 280-284

Authors: Yee, TT Murphy, K Johnson, M Abdalla, SH Patton, GS Lee, CA Mehta, AB
Citation: Tt. Yee et al., Multiple myeloma and human immunodeficiency vivus-1 (HIV-1) infection, AM J HEMAT, 66(2), 2001, pp. 123-125

Authors: Nitu-Whalley, IC Lee, CA Hermans, C
Citation: Ic. Nitu-whalley et al., Reassessment of the correlation between the von Willebrand factor activity, the PFA-100((R)), and the bleeding time in patients with von Willebrand disease, THROMB HAEM, 86(2), 2001, pp. 715-716

Authors: Zhang, KYE Hee, B Lee, CA Liang, BH Potts, BCM
Citation: Kye. Zhang et al., Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease, DRUG META D, 29(5), 2001, pp. 729-734

Authors: Kadir, RA Lee, CA
Citation: Ra. Kadir et Ca. Lee, Menorrhagia in adolescents, PEDIAT ANN, 30(9), 2001, pp. 541-546

Authors: Loftin, CD Trivedi, DB Tiano, HF Clark, JA Lee, CA Epstein, JA Morham, SG Breyer, MD Nguyen, M Hawkins, BM Goulet, JL Smithies, O Koller, BH Langenbach, R
Citation: Cd. Loftin et al., Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2, P NAS US, 98(3), 2001, pp. 1059-1064

Authors: Sabin, CA Lepri, AC Devereux, H Phillips, AN Loveday, C Lee, CA
Citation: Ca. Sabin et al., Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia, J INFEC DIS, 184(4), 2001, pp. 511-514

Authors: Chan, WL Pejnovic, N Lee, CA Al-Ali, NA
Citation: Wl. Chan et al., Human IL-18 receptor and ST2L are stable and selective markers for the respective type 1 and type 2 circulating lymphocytes, J IMMUNOL, 167(3), 2001, pp. 1238-1244

Authors: Lucas, RL Lee, CA
Citation: Rl. Lucas et Ca. Lee, Roles of hilC and hilD in regulation of hilA expression in Salmonella enterica serovar typhimurium, J BACT, 183(9), 2001, pp. 2733-2745

Authors: Lostroh, CP Lee, CA
Citation: Cp. Lostroh et Ca. Lee, The HilA, box and sequences outside it determine the magnitude of HilA-dependent activation of P-prgH from Salmonella pathogenicity island 1, J BACT, 183(16), 2001, pp. 4876-4885

Authors: Sabin, CA Devereux, H Phillips, AN Hill, A Janossy, G Lee, CA Loveday, C
Citation: Ca. Sabin et al., Course of viral load throughout HIV-1 infection, J ACQ IMM D, 23(2), 2000, pp. 172-177

Authors: Yee, TT Lee, CA
Citation: Tt. Yee et Ca. Lee, Oral immune tolerance induction to factor VIII via breast milk, a possibility?, HAEMOPHILIA, 6(5), 2000, pp. 591-591

Authors: Lee, CA
Citation: Ca. Lee, International hemophilia training centres for new professionals, HAEMOPHILIA, 6, 2000, pp. 46-46

Authors: Kadir, RA Sabin, CA Goldman, E Pollard, D Economides, DL Lee, CA
Citation: Ra. Kadir et al., Reproductive choices of women in families with haemophilia, HAEMOPHILIA, 6(1), 2000, pp. 33-40

Authors: Lee, CA
Citation: Ca. Lee, Hepatitis C infection and its management, HAEMOPHILIA, 6, 2000, pp. 133-137

Authors: Lee, CA
Citation: Ca. Lee, World Federation of Haemophilia Treatment of Haemophilia Monograph series - Introduction, HAEMOPHILIA, 6, 2000, pp. V-V

Authors: Miners, AH Sabin, CA Tolley, KH Lee, CA
Citation: Ah. Miners et al., Primary prophylaxis for individuals with severe haemophilia: how many hospital visits could treatment prevent?, J INTERN M, 247(4), 2000, pp. 493-499

Authors: Lostroh, CP Bajaj, V Lee, CA
Citation: Cp. Lostroh et al., The cis requirements for transcriptional activation by HilA, a virulence determinant encoded on SPI-1, MOL MICROB, 37(2), 2000, pp. 300-315

Authors: Lucas, RL Lee, CA
Citation: Rl. Lucas et Ca. Lee, Unravelling the mysteries of virulence gene regulation in Salmonella typhimurium, MOL MICROB, 36(5), 2000, pp. 1024-1033

Authors: Nitu-Whalley, IC Riddell, A Lee, CA Pasi, KJ Owens, D Enayat, MS Perkins, SJ Jenkins, PV
Citation: Ic. Nitu-whalley et al., Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients. a reappraisal using phenotypes, genotypes and molecular modelling, THROMB HAEM, 84(6), 2000, pp. 998-1004
Risultati: 1-25 | 26-50 | 51-66